Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea

Sleep and Breathing

Volumn 13, Issue 4, 2009, Pages 391-395

  Al Lawati, Nabil ^a,d   Mulgrew, Alan ^a   Cheema, Rupi ^a   vanEeden, Stephan ^c   Butt, Arsalan ^a   Fleetham, John ^a   Ryan, Frank ^a   Ayas, Najib ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d ROYAL HOSPITAL   (Oman)

Author keywords

Cardiovascular disease; Cytokine; Inflammation; Sleep apnea

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYHEMOGLOBIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CYTOKINE PRODUCTION; DISEASE SEVERITY; FATTY ACID DESATURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP TIME;

ADULT; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEPTIN; MALE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; REFERENCE VALUES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 70350270371     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-009-0259-1     Document Type: Article

References (24)

1. Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365:1046-1053
2. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143. doi: 10.1161/hc0902.104353
3. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343:1139-1147. doi: 10.1056/NEJM200010193431602
4. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772
5. Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA (2004) Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44:1812-1818. doi: 10.1016/ j.jacc.2004.07.047
6. Ballantyne CM (2001) Newer risk markers and surrogate endpoints in atherosclerosis management. Clin Cardiol 24(8 Suppl):III13-III17
7. Ryan S, Taylor CT, McNicholas WT (2006) Predictors of elevated nuclear factor κB dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174:824-830. doi: 10.1164/rccm.200601-066OC
8. Gozal D, Kheirandish-Gozal L (2008) Cardiovascular morbidity in obstructive sleep apnea: Oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 177:369-375. doi: 10.1164/rccm.200608-1190PP
9. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179-184
10. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-14
11. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ (2002) Adhesion molecules in patients with OSA and CAD. Chest 121(5):1541-1547. doi: 10.1378/chest.121.5.1541
12. Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129-1134. doi: 10.1161/ 01.CIR.0000052627.99976.18
13. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F (2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165:67-70
14. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, Lavie P (2002) Plasma vascular endothelial growth factor in sleep apnea syndrome effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165:1624-1628. doi: 10.1164/rccm.20110-040OC
15. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62(6):509-514. doi: 10.1136/ thx.2006.066720
16. AASM (1999) Sleep related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in adults. Sleep 22:667-689
17. McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: A matched controlled study. Am J Respir Crit Care Med 175(2):190-195. doi: 10.1164/ rccm.200602-270OC
18. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: Effect of CPAP treatment. Eur Respir J 22(2):251-257. doi: 10.1183/09031936.03.00010103
19. Ip MS, Lam KS, Ho C, Tsang KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118(3):580-586. doi: 10.1378/chest.118.3.580
20. Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122(3):829-839. doi: 10.1378/chest.122.3.829
21. Minoguchi K, Yokoe T, Tazaki T. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea
22. Tam CS, Wong M, Tam K, Aouad L, Waters KA (2007) The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-alpha, and CRP levels in piglets. Sleep 30(6):723-727
23. Kohler M, Ayers L, Pepperell JC, Packwood KL, Ferry B, Crosthwaite N, Craig S, Siccoli MM, Davies RJ, Stradling JR (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: A randomised controlled trial. Thorax 64(1):67-73.
24. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290-1297. doi: 10.1164/ rccm.200612-1771OC